1-2 of 2
Maria C Carraro
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

REL-Protocol PhilosoPhi34: An Open Label, Single Arm, Phase II Study of Nilotinib 300 Mg BID in Newly Diagnosed Chronic Phase Chronic Myeloid Leukaemia Patients, to Study the Disappearance of CD34+/Lin-Ph+ Cells from Bone Marrow during Treatment. Preliminary Data

Ester Pungolino, MD, Giuseppe Rossi, MD, Maria Angela Mura, Alessandra Perego, MD, Ester Maria Orlandi, MD, Mauro Turrini, MD, Lorenza Borin, MD, Maria Adele Capucci, MD, Alessandra Iurlo, MD PhD, Alessandra Trojani, PhD, Mariella D'Adda, MD, Francesco Spina, MD, Gabriella De Canal, Maria Luisa Pioltelli, Maria Luisa Latargia, MD, Sergio Pauli, MD, Chiara Elena, MD, Stefania Brusorio, Francesco Lanza, MD, Simona Malato, MD, Michela Anghilieri, MD, Maria C Carraro, MD, Enrica Morra, MD, Roberto Cairoli, MD
Journal: Blood
Blood (2015) 126 (23): 1597.
https://doi.org/10.1182/blood.V126.23.1597.1597
Published: 2015
Journal Articles

Frequency and Determinants of Thrombotic and Bleeding Complications in Ph Negative Myeloproliferative Neoplasms (MPN): The Role of Adamts-13 and VWF Activities in an Italian Cohort 0f 88 Well Characterized Patients

Augusto B. Federici, MD, Maria C Carraro, Antonella Lattuada, Chiara Vanelli, Veronica Sciumbata, Valentina Rossi, MD, Daniela Intini, Sarah Birindelli, Sara Munizza, Elisabetta Sacchi, Umberto Russo, Ulrich Budde, MD
Journal: Blood
Blood (2012) 120 (21): 3369.
https://doi.org/10.1182/blood.V120.21.3369.3369
Published: 2012